McDermott Health Podcast Channel

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Farragut's own Assistant Vice President, Holly Stokes. Holly provides an update and 2024 outlook for the No Surprises Act (NSA). They discuss the carve out, as well as the status of the committee and their recommendations. Along with this update, they share their thoughts on the NSA's potential impact on the industry.

The Driving the Deal podcast is back for its fourth season! We're bringing you the latest topics impacting the healthcare private equity space. In this new episode, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, McDermott Partner and co-head of the Firm's Private Equity Practice Group, are joined by Farragut Square Group's Assistant Vice President, Holly Stokes, and Director of Research, Jackie Williams, to provide insights from the 2024 J.P. Morgan Healthcare Conference in San Francisco. Together, they discuss what people are expecting this year in the deal market, providing key takeaways and sharing their thoughts on various sector themes.

In this episode, McDermott partner Dale Van Demark sits down with Liz Rockett for her thoughts on working at the intersection of investor-driven and mission-driven healthcare investment, the role of entrepreneurs in driving healthcare innovation, what's driving the flow of investor dollars into the digital health space and more.

In this episode, McDermott partner Bernadette Broccolo sits down with Dr. Broyles for his thoughts on the measures and avenues for health system success in implementing new digital health technologies, the areas of digital health innovation driving health system digital health strategies, the importance of balancing health system innovation imperatives and enterprise risk tolerance and more.

In this episode, McDermott partner Sharon Lamb sits down with Andrew Davies for his thoughts on UK's digital health market, medical device regulation, areas for digital health opportunity, Brexit's impact on healthcare innovation and more.

In this episode, McDermott partner Marshall Jackson sits down with Michelle Davey for her thoughts on virtual care's role in strengthening health infrastructure, provider-focused telehealth solutions, driving forces behind the growth of telehealth and more.

In this episode, McDermott Digital Health partner Dale Van Demark sits down with Dr. Karen Murphy for her thoughts on how healthcare systems can make accesses easier for patients, the growing disruption and innovation in the healthcare industry, closing the digital divide and more.

Digital Health partner Dale Van Demark sits down with Dr. Chaudhry to learn how the Federation of State Medical Boards (FSMB) is advancing the interstate practice of medicine, the role of state boards in digital health adoption, the importance of prioritizing physician mental health and more.

In this episode, McDermott Digital Health Co-Chair Lisa Mazur sits down with Lee for his thoughts on key ingredients of a successful digital health solution, what he looks for in early-stage companies, top trends in digital health and more.

In this episode, McDermott Digital Health Co-Chair Stephen Bernstein discusses innovation opportunities presented by the interoperability rule, the importance of practical application in rulemaking and more.

In this episode, McDermott Digital Health partner Jennifer Geetter sits down for a candid conversation on the state of digital care in the US, the importance of data sharing for effective care and public health, and more.

The board's executive compensation committee has traditionally been one of the most prominent of all board functions, with its focus on such interconnected responsibilities as oversight of the executive compensation process, compensation data analysis, talent recruitment and executive search.   This episode is the first in a two-part discussion filled with valuable insight and the latest developments affecting compensation committees from two recognized health industry compensation and benefits experts, Tim Cotter and Ralph DeJong. Tim and Ralph will discuss such important topics as:   - The current state of salary, increase budgets, incentive award levels and emerging compensation practices. - Developing retention and predictable transition strategies. - Insights into application and interpretation of the IRS “rebuttable presumption” standards. - Needed changes to highly prescriptive compensation philosophies. - Tactics for encouraging executive retention beyond traditional cash incentives.

It's the perfect time of year to take stock of the leading developments of the prior 12 months and consider what lessons they have to offer us. This valuable exercise for corporate directors can put them in a better position from which to address the looming agenda items their boards face in 2023. For directors of healthcare companies, governance trends range from the economy to the corporate social voice, ESG to mission-critical corporate risks with many stops in between. To lead this review, Michael Peregrine sits down with Charles Elson, Founding Director, Weinberg Center for Corporate Governance, Retired, Willard Shared, Corporate Governance, University of Delaware, and Executive Editor at Large, Directors & Boards. Charles offers a comprehensive review of the leading governance issues of 2022, as well as a look at what may be to come in 2023.

On this episode - the third in our new Governing Health special edition series - Ken Kaufman, Co-Founder and Managing Director of Kaufman Hall and Michael Peregrine discuss the board's top post-pandemic governance challenges, including:   > The concept of “languishing” within companies in the wake of COVID-19 > Strategic planning tactics to resume normal organization activity > The critical need to maintain a competitive advantage post COVID-19 > Maintaining growth through M&A activity given increased antitrust enforcement > Board/executive partnering to address nonprofit healthcare's role in the ESG movement > Confronting the dramatically expanded post-pandemic board agenda

The restatement of the law of charitable non-profit organizations provides helpful and useful summaries regarding what contributors believe to be the state of the law. On this episode of the Governing Health podcast host Michael Peregrine welcomes legal scholar and policy expert Professor Jill Horwitz to help bring clarity to the restatement of the law of charitable non-profit organizations. Professor Horwitz offers key insights into the scope of this new publication regarding the topics it covers, the relevance it provides and suggestions on how to best use this research on behalf of our health system clients.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, sit down with John Jamison, Director of Healthcare Investment Banking at Cantor Fitzgerald. Together, they discuss the macroenvironment of the allergy and ENT space, commenting on what's sparking interest in the sector and what's in store for the next year. Additionally, they take a look at the service mix and provide thoughts on investing in the space.

We're delighted to offer the latest episode in our popular series of podcast dialogues with Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall.   In this episode, Ken and podcast host Michael Peregrine return to the social science concept of “wicked problems”—problems that have no single, correct solution. In fact, a solution that improves one aspect of a wicked problem usually makes another aspect of the problem worse.   Ken believes that the current hospital operating environment is overwhelmed by wicked problems, and during the conversation, he shares his insight on: How wicked problems impact hospital-client issues Keeping management and boards appropriately informed and engaged, including key metrics that board members must be aware of Balancing the crisis of regulation with a hospital's need to scale Addressing and debriefing the board on post-COVID-19 strategies Managing media and political attacks on hospitals   Additional Resources:  

We're delighted to offer the latest episode in our popular series of podcast dialogues with Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall.   In this episode, Ken and podcast host Michael Peregrine return to the social science concept of “wicked problems”—problems that have no single, correct solution. In fact, a solution that improves one aspect of a wicked problem usually makes another aspect of the problem worse.   Ken believes that the current hospital operating environment is overwhelmed by wicked problems, and during the conversation, he shares his insight on: How wicked problems impact hospital-client issues Keeping management and boards appropriately informed and engaged, including key metrics that board members must be aware of Balancing the crisis of regulation with a hospital's need to scale Addressing and debriefing the board on post-COVID-19 strategies Managing media and political attacks on hospitals   Additional Resources:  

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by his colleague, Sharon Lamb, Partner and head of the U.K. health practice at McDermott Will & Emery. Together, they debrief HPE Europe 2023, discussing their findings on investment trends and opportunities, as well as current market challenges. They also provide insight on innovative advancements, market dynamics, and forecasts for 2024.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Houlihan Lokey's own Mark Francis, Managing Director and Global Head of its Healthcare Group. Together, they discuss the sectors expected to see an increase in deal volume and activity, a review of activity and deal flow in the last three quarters, sectors that are cooling off, the impact of digital health in the healthcare industry, and an outlook for the rest of the year and 2024.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by FSG's own Assistant Vice President, Holly Stokes, in an insightful overview of the recently released 2024 Physician Fee Schedule (PFS) proposed rule. They shed light on the PFS's significance and impact on providers. Holly provides a comprehensive overview of the proposed changes, including the notable 3.4% cut to the conversion factor, and presents an outlook for potential congressional intervention as well as other specialty-specific changes.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for the final segment of our three-part behavioral health series. Together, they have a riveting conversation on the psychiatry space, discussing today's macro-environment and service mix. Additionally, they provide insights on current reimbursement issues and investment opportunities within the sector.

During this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for part two in our three-part behavioral health series. Together, they delve into the substance use disorder (SUD) space and its macro environment. They also share their thoughts on the evolving demand for relevant services in recent years and provide valuable insights on investment opportunities within the SUD sector.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Dan Beuerlein, managing director at Brentwood Capital Advisors. Embarking on a three-part behavioral health series, Brian and Dan discuss the autism space, including the macro environment for autism, as well as the service mix and evolution. They also share their thoughts on investing in the autism space.  

In this episode, hosts Kristian Werling, McDermott partner and co-head of the Firm's Private Equity Practice Group and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott's 2023 HPE Miami event. Together, they share key themes from the conference, discuss current healthcare deal market highlights and chat about various areas of interest and activity in spaces such as infusion/AICs, cardiology, ophthalmology, home care personal services, payor services, etc. Brian and Krist also share their thoughts on the timing of market activity and Silicon Valley Bank's impact on the market.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, are joined by Brown Gibbons Lang & Company's own John M. Tiedmann Jr., Director and senior member, and J. Kyle Brown, Managing Director and senior member of their Healthcare & Life Sciences team. They discuss the current state of the deal market and deal flow and provide insight into the most active spaces in healthcare and the macro market forces affecting opportunities this year.

In the 14th episode of Season 2: Driving the Deal, Krist Werling, McDermott Will & Emery partner and co-head of the Firm's private equity practice, and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott's 2022 HPE New York event. Together, they share key themes from the conference and discuss current healthcare deal market highlights, including: The trends slowing down large deals while also powering activity in the low and middle market The current debt market, outlook for 2023 and potential financing opportunities A look at the activity within the pharmaceutical services space An overview of recent CMS rulemaking (e., PFS, OPPS, home health and ESRD)  The future of dealmaking as we head toward a potential recession

The board's executive compensation committee is the focus point for many of the extraordinary financial, economic and operating challenges currently facing healthcare organizations. Executive compensation increases are impacted by both an inflationary economy and significant revenue downturn. In addition, the Department of Justice has identified executive compensation as an important conduit through by which corporate compliance incentives and deterrence can be implemented. Furthermore, executive recruitment and retention amidst the “Great Resignation” remains a key compensation concern.   These and similar issues have become important agenda items for the board's executive compensation Committee. Michael Peregrine is joined by industry experts Tim Cotter and Ralph DeJong for the first in a two-part conversation about the impact of the developments on the compensation committee, including:   Key topics for briefing the board's compensation committee. Increasing communication between the compensation committee and the C-Suite. Addressing pressures felt by executive committee members. Insights from the Sullivan Cotter compensation data survey. Projections for the impact of inflation on next year's salary increases. Expectations for future CEO salary increases and organization departures. The segmenting approach to leadership plans. Coordination with the Audit & Compliance Committee on compensation incentives

Nonprofit healthcare organizations and their governing boards are subject to the authority of the state attorney general, which has broad statutory and common law power with respect to its duty to preserve charitable assets. The attorney general is supported in this work by dedicated charity officials who work within what is normally referred to as the “charitable trust division” of the attorney general's office.   To help inform nonprofit health systems and their leaders on the role of the attorney general and its charity regulators, Michael Peregrine is joined by Leslie Friedlander, an Assistant Attorney General in the office of the Texas Attorney General. Leslie is currently the president of the National Association of State Charity Officials (NASCO), and offers a “refresher course” about state regulation of nonprofit organizations, and NASCO's related educational role, including: An overview of the role of NASCO, its purposes, and the value of its educational materials. Charity officials' interest in nonprofit board business practices. How state charity officials gather information that informs enforcement policies. Effective means of communication between the charitable sector and NASCO. Examples of what a state charity official might consider as “red flag activities” by a nonprofit and its board. Other divisions within the Attorney General's office that may get involved with charitable trust decisions. NASCO's priorities and policies for the coming year.

Corporate directorship continues relentlessly to increase in complexity. The ability of directors to fully engage with the board agenda and to be effective partners in management are two of the most critical corporate governance issues in the current environment. These are issues that implicate a level of commitment by directors to be informed, attentive, and up to speed on their duties and on the issues of importance to the organization that they serve. This commitment is made even more critical this year by the many turns of events that are impacting the agenda in many boardrooms.   To learn more about how directors at leading companies are handling this increase in role complexity board communication, Kimberly Simpson, the COO of NACD (the National Association of Corporate Directors) which serves both for-profit and nonprofit directors and boards, and offers the country's premier director certification program, joins Michael Peregrine for a conversation about the multifactorial challenges facing boards today, including: The role of directors in understanding today's topsy turvy economic environment Where private and public company directors place inflation within other boardroom priorities ESG challenges and opportunities The important role of board refreshment Top trends from NACD's public and private company surveys Updates on NACD Directorship Certification®

In Season 2, Episode 13 of Driving the Deal, Farragut Square Group's (FSG) Brian Fortune and Jackie Williams are joined by FSG's Assistant Vice President Hope Amsterdam. In this episode, they discuss recent reimbursement-related developments for Medicare and Medicaid on the state level, as well as: Major Medicare and Medicaid investments made by states during the most recent budget cycle Positive July rulemaking for post-acute care and inpatient psychology Reimbursement adjustments for hospice, inpatient rehabilitation facilities and inpatient psychology Case-mix adjustments to the positive skilled nursing facility (SNF) patient-driven payment model Centers for Medicare & Medicaid Services' (CMS) final rule for SNFs Home Health proposed "Temporary” and “Permanent” adjustments

In the 12th episode of Season 2: Driving the Deal, Farragut Square Group's (FSG) Brian Fortune and Jackie Williams are joined by Holly Stokes, senior research associate at FSG, for a discussion on the future of physician practice management (PPM). Specifically, the trio delves into the regulatory actions that occurred within the PPM sector this past year as we head into end-of-year legislation and rulemaking, as well as the anticipated pressures for market participants in 2023 and 2024. In this episode, they also talk about: Regulatory changes for PPM companies Proposed cuts to the Physician Fee Schedule Implications of the ruling in Dobbs v. Jackson Women's Health Organization on the fertility and OBGYN sectors Drug pricing provisions in the Inflation Reduction Act of 2022 Future implementation of the No Surprises Act and qualifying payment amount calculation

In the 11th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined for a guest interview hosted by Farragut Square Group's own Jackie Williams and Hope Amsterdam. In this episode, Hope and Jackie interview Damon Terzaghi, senior director of LTSS policy at the National Association of States United for Aging and Disabilities, to provide an overview of the home- and community-based services (HCBS) space. Together, they discuss the following:  The increase in demand for HCBS before and after COVID-19 The increased Federal Medical Association Percentages reimbursement for HCBS The likelihood of increased funding to exist beyond the public health emergency Labor issues surrounding the HCBS space Priorities for states surrounding HCBS after the pandemic  

In the 10th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Mark Francis, managing director at Houlihan Lokey and head of its Healthcare Group, as they summarize the end of Q2 for the healthcare industry. Together, they discuss the following:  Healthcare sectors poised to see an increase in deal volume and activity A review of activity and deal flow in Q1 and Q2 Sectors that are cooling off post-Q1 and Q2 The impact of digital health on the healthcare industry Sectors heading into distress territory Q3 insights

To highlight the important connections between financial risk management, the credit rating process and effective governance, Michael Peregrine welcomes Lisa Goldstein, Senior Vice President at Kauffman Hall and a nationally recognized analyst, speaker, writer and expert on nonprofit healthcare, for a conversation exploring:  The responsibilities of a strong finance committee The value of subject matter expertise within the finance committee Key metrics that rating agencies use to evaluate governance Insights from high-performing healthcare system boards The role of covenant management in repayment performance Lessons learned from the pandemic, including credit-related crisis management ESG issues for nonprofit healthcare  

In the newest episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Ashley Fischer, McDermott health antitrust partner. Together, they discuss the following concerning healthcare antitrust in the Biden administration: The Federal Trade Commission's (FTC) signaled interest in the effect of private equity on competition How the FTC views hospital consolidation Major cases in the physician market and subsequent enforcement activity Tips for investing with new scrutiny Labor market competition and recent significant cases

In episode 8 of Season 2: Driving the Deal, Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by Elle Kalisz, a research analyst at FSG, and Swatee Survee, CEO and founder of Litesprite. Together, they explore all things digital technology, including: What is a Digital Therapeutic? What makes a Digital Therapeutic different from traditional digital health tools? The intersection of digital self-help tools and mobile gaming. Provider, payor and employer uptake/participation. Insights for investors interested in the digital technology space.

July 30, 2022, marks the 20th anniversary of the Sarbanes Oxley Act, one of the most consequential pieces of federal financial regulation ever enacted into law. It serves as the foundation for many of the guidelines and principles that are now considered routine by boards and their audit, compensation and finance committees. It's difficult to overstate the continuing impact of Sarbanes on corporate governance. Thus, given the passage of time there is value in board members refreshing their familiarity with the Sarbanes history, in order to better appreciate its influence.   To help underscore the Sarbanes legacy, Michael Peregrine welcomes back Scott Steffens, well-known audit partner in Grant Thornton's national nonprofit and educational practice. In their conversation, Scott and Michael review the circumstances that led to Sarbanes's enactment, and how auditor, management and audit committee interactions have changed over the last 20 years, particularly in the nonprofit and healthcare sectors, including: - The role and function of the Audit Committee - The continuing importance of independent directors in Committee membership - The frequency and length of Audit Committee meetings - Rotation of the lead audit partner - Preserving auditor independence - Internal consideration of issues raised in “Management Letter” - Related party disclosures

In Season 2, Episode 7 of Driving the Deal, Krist Werling, McDermott partner and co-head of the Firm's Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Brian Stimson, a partner in McDermott's Healthcare Practice Group and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services. Together they discuss current litigation surrounding the impending future of the No Surprises Act, as well as: -The specialties most impacted by the legislation and subsequent litigation - An overview of the No Surprises Act and current litigation surrounding it -The Act's impact on providers -Next steps for future litigation

Recent events have made it clear that the board won't be retreating any time soon from a high level of engagement with management on patient care and safety matters, but what is the appropriate level of board engagement? To answer that question, welcomes back , president of Orlikoff & Associates, Inc., and , MWE partner, leader of McDermott health advisory on patient care and safety and accreditation issues, and author of the recent client memo series on vaccination mandates and workplace safety developments, for an update on where we stand two years into the COVID-19 pandemic, including:   Implications and expectations from hospital boards regarding current COVID-19 rates. The regulatory authorities response to competing pandemic-related pressures. Board guidance for addressing financial concerns in light of a stealth surge  The governance challenges associated with growing supply chain issues.  Universal truths following the pandemic that are valuable to healthcare boards.  Defining purpose and the role of hospitals in leading healthcare issues.  Additional Resources:  

In the sixth episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Brian Stimson, Healthcare Partner at McDermott Will and Emery and former Acting General Counsel & Principal Deputy General Counsel for US Department of Health and Human Services, discuss the unwinding of the COVID-19 Public Health Emergency (PHE). They discuss the following topics:  Expected end of the COVID-19 PHE Conclusion and future of telehealth flexibilities Medicaid eligibility issues associated with the end of the PHE Remaining PREP Act Declarations Next moves for CMS and other agencies

The key topics that should be receiving board attention in the near term have less to do with traditional operational matters, and more to do with social and economic issues of concern to the workforce and the mission. To bring understanding to these key concerns, we turn to our quarterly conversation with Ken Kaufman, Co-Founder and Managing Director of Kaufman Hall.   Ken has been visiting with clients and other leaders of the healthcare industry and has also been busy with his popular blog, addressing pressing subjects ranging from inflation to artificial intelligence. Ken has returned to our podcast today to share his insights on topics that include: Social justice board initiatives that have developed in the wake of the George Floyd murder. The impact of individual actions regarding equality at the CEO level. Addressing current workforce culture and employee retention concerns. The impact of rising inflation rates on hospitals and health systems. Realities and expectations of today's board members. Forward-thinking advice for board members and directors. Additional Resources:  

In the fifth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Holly Stokes, Senior Associate at Farragut Square Group, are joined by Justin Santa Cruz, Chief Development Officer at US Eye, an integrated, multi-specialty eye care platform. Recording live at McDermott's annual Physician Practice Management & ASC Symposium in Nashville, Brian, Holly and Justin discussed: Operational and demand changes US Eye made in response to COVID-19 Current challenges and opportunities in the ophthalmology space Key features of ophthalmology assets for acquisitions and expansion The increasing role of private equity in ophthalmology The outlook for M&A activity in ophthalmology for 2022

The social and economic phenomenon known as “the Great Resignation” is now impacting hospital and healthcare CEOs. This, according to important new analysis from the well-known outplacement and search firm Challenger Gray & Christmas. To provide boards with a perspective on rising incidents of CEO resignation and their impact on healthcare organizations, we turn to our quarterly conversation with John Challenger and on the CEO employment status.   In this episode, host Michael Peregrine and John Challenger offer members of the board executive search, finance and HR committees an important update regarding CEO resignation trends, as well as an interpretation of economic data as it may impact health systems. Insights include:   Findings from the Challenger, Gray & Christmas report and their implications for the board's search and succession process. Recommendations to boards regarding CEO monitoring and succession planning. How cultural changes and concerns are prompting the increase of CEO resignation. Key warning signs of CEO fatigue. Observations regarding leading economic indicators in the second quarter; e.g. inflation, unemployment rate and job participation statistics. Final words of caution for board consideration.   Additional Resources:  

In the fourth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Jackie Williams, Head of Research at Farragut Square Group, are joined by Holly Stokes, Senior Associate at Farragut Square Group, live at McDermott's annual Physician Practice Management & ASC Symposium in Nashville. Brian, Jackie and Holly discuss:  The stability and continued interest in gastroenterology and ophthalmology Specialties emerging as the next frontier for PPMs Challenges and special considerations for cardiology and ambulatory infusion The current macro pressures for PPMs including budget neutrality, clinical labor, sequester and pay-go

Part two of this series addresses key issues facing the board's compensation committee when evaluating executive compensation, data analysis, recruitment and retention, and executive search matters.   This episode features industry leaders, Tim Cotter and Ralph DeJong, as they offer extraordinary insight on emerging priorities and trends impacting the compensation committees, including:   The evolution of annual and long-term incentive plans. The retention effect of executive pay and benefit programs. The continued relevance of for-profit compatibility data. Handling executive and director co-investment arrangements. Approaching CEO compensation earned from outside board service.

The board's executive compensation committee has traditionally been one of the most prominent of all board functions, with its focus on such interconnected responsibilities as oversight of the executive compensation process, compensation data analysis, talent recruitment and executive search.   This episode is the first in a two-part discussion filled with valuable insight and the latest developments affecting compensation committees from two recognized health industry compensation and benefits experts, and . Tim and Ralph will discuss such important topics as:   The current state of salary, increase budgets, incentive award levels and emerging compensation practices. Developing retention and predictable transition strategies. Insights into application and interpretation of the IRS “rebuttable presumption” standards. Needed changes to highly prescriptive compensation philosophies. Tactics for encouraging executive retention beyond traditional cash incentives.

In the third episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Mark Francis, Head of Healthcare and Managing Director at Houlihan Lokey, live at McDermott's annual Health Private Equity event in Miami. They discuss the following topics:  Healthcare sectors poised to see an increase in deal volume and activity Convergence of sectors creating new services in the next five years Future of orthopedic deals and changing sector activity “Transformative” deals and entering the innovative side of healthcare Value-based care and its impact on the market

On this episode of In the Trenches, McDermott partner and program host Brian Stimson continues his conversation with and of Epsilon Consulting and , Vice President of to discuss their thoughts on the Cares Act and Provider Relief Funds, including:   Pain points for providers on PRF compliance and enforcement Proactive steps to mitigate PRF fund risk regarding balance billing A simple and conservative approach to the loss of revenue methodology Risks and considerations presented with “double-dipping” Best practices for providers to mitigate risk in 2022 Points when engaging with HRSA Additional Resources:  

On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with and of Epsilon Life Sciences and , Vice President of to review the history of the PRF, the big pain points for PRF recipients, and what to do about them, including:   How HHS stood up the PRF at the height of the pandemic How different PRF recipients operationalized the program requirements What providers can still do if HHS denied some or all the PRF funds they sought How the recent history informs current PRF reporting and enforcement risks The biggest reporting and compliance pain points for PRF recipients What PRF recipients should expect, and do next Additional Resources:  

In this second episode of Season 2 of Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Frank Martin, Head of Commercial Care at Farragut Square Group and a leader in commercial managed care. The topics discussed include: - The dominant trends in the commercial care market heading into 2022 - The state of beneficiary enrollment in Medicare Advantage - Managed care payor interaction in the Behavioral Health space and Medicaid - Proactive revisions to change of control specifications in deal contracts